Q3 2017 Holdings
Filed 2017-11-14 | 63 holdings | $28.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $8.0M | 275,000 | 28.5% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $7.3M | 200,000 | 25.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $5.7M | 252,534 | 20.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $4.1M | 35,000 | 14.6% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $2.6M | 500,000 | 9.3% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $30.3K | 350,000 | 0.1% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $27.2K | 1,946,946 | 0.1% |
| Zogenix IncPut | COM NEW | 98978L204 | $22.8K | 650,000 | 0.1% |
| Zogenix Inc | COM NEW | 98978L204 | $21.0K | 600,000 | 0.1% |
| Avexis IncPut | COM | 05366U100 | $19.3K | 200,000 | 0.1% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $17.9K | 420,886 | 0.1% |
| DBV Technologies S APut | SPONSORED ADR | 23306J101 | $17.1K | 403,500 | 0.1% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $14.0K | 100,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $13.8K | 225,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $13.1K | 350,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $10.5K | 115,000 | 0.0% |
| Entellus MED Inc | COM | 29363K105 | $10.4K | 561,510 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $10.1K | 324,400 | 0.0% |
| Avexis Inc | COM | 05366U100 | $10.1K | 104,539 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $9.6K | 150,000 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $9.5K | 50,000 | 0.0% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $9.4K | 300,000 | 0.0% |
| Sage Therapeutics Inc(SG7)Put | COM | 78667J108 | $9.3K | 150,000 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $9.1K | 950,000 | 0.0% |
| Zimmer Biomet Hldgs Inc(ZBH) | COM | 98956P102 | $8.8K | 75,000 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $7.8K | 65,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $7.8K | 250,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $7.6K | 50,000 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $7.1K | 80,000 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $7.0K | 135,000 | 0.0% |
| Ignyta Inc | COM | 451731103 | $6.8K | 550,000 | 0.0% |
| Patterson Companies Inc(PDCOEUR) | COM | 703395103 | $6.2K | 160,000 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD)Call | COM | 45845P108 | $5.8K | 100,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $5.7K | 400,000 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $5.6K | 345,284 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $5.1K | 50,000 | 0.0% |
| Aimmune Therapeutics Inc(AIMT) | COM | 00900T107 | $5.0K | 200,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $4.8K | 75,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $4.5K | 100,000 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $4.5K | 100,000 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $4.2K | 65,000 | 0.0% |
| Acadia Pharmaceuticals Inc(ACAD)Call | COM | 004225108 | $4.1K | 109,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $4.1K | 35,000 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $4.0K | 700,000 | 0.0% |
| Currencyshs Brit Pound Ster | BRIT POUND STE | 23129S106 | $3.9K | 30,100 | 0.0% |
| Aimmune Therapeutics Inc(AIMT)Call | COM | 00900T107 | $3.7K | 150,000 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $3.7K | 400,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $3.6K | 75,000 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $3.4K | 235,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $3.0K | 200,000 | 0.0% |